Polaris Pharmaceuticals Group (6550) announced on May 22, 2026, that it has completed the payment for its 2nd private placement of common shares for the 114th fiscal year, setting the capital increase record date to the same day. The company issued 34,900,000 shares at a price of 18 TWD per share, totaling 628,200,000 TWD. This capital increase was conducted within the limit of 150,000,000 shares approved by the extraordinary shareholders' meeting on December 26, 2025. All funds have been fully collected.

FACT BOX

  • Source: PR Times
  • Category: capital_increase